Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
-5.13M
-
Total reported value, excl. options
-
$72.4M
-
Value change
-
-$13.5M
-
Put/Call ratio
-
0.86
-
Number of buys
-
24
-
Number of sells
-
-46
-
Price
-
$2.32
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q2 2021
88 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q2 2021.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
.
Largest 10 shareholders include BVF INC/IL (9.54M shares), NEA Management Company, LLC (9.09M shares), VANGUARD GROUP INC (2.27M shares), ACADIAN ASSET MANAGEMENT LLC (1.95M shares), DIMENSIONAL FUND ADVISORS LP (1.18M shares), BlackRock Inc. (886K shares), RENAISSANCE TECHNOLOGIES LLC (758K shares), TWO SIGMA ADVISERS, LP (709K shares), MILLENNIUM MANAGEMENT LLC (687K shares), and GEODE CAPITAL MANAGEMENT, LLC (353K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.